Saba Capital Management, L.P. Teva Pharmaceutical Industries LTD Transaction History

Saba Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $519,180 - $702,134	-48,658 Reduced 27.08%	131,005 $1.85 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $75,840 - $99,284	-9,340 Reduced 4.94%	179,663 $1.88 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $477,485 - $683,034	-63,835 Reduced 25.25%	189,003 $1.93 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $304,992 - $401,149	42,360 Added 20.13%	252,838 $1.9 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $1.46 Million - $1.98 Million	174,230 Added 480.66%	210,478 $1.86 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $288,171 - $343,631	36,248 New	36,248 $330,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Saba Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Saba Capital Management, L.P. with notifications on news.